In patients with decompensated cirrhosis, sarcopenia and frailty are prevalent. Although
several definitions exist for these terms, in the field of hepatology, sarcopenia has commonly …

Malnutrition is a common complication in patients with end‐stage liver disease (ESLD)
awaiting liver transplantation (LT). Malnutrition and sarcopenia overlap in etiology and …

Background: Surgeons have historically used age as a preoperative predictor of
postoperative outcomes. Sarcopenia, the loss of skeletal muscle mass due to disease or …

Background The global prevalence of non-alcoholic steatohepatitis (NASH) is increasing,
such that NASH is predicted to become the leading cause of liver transplantation (LT) in the …

Chronic liver disease (CLD), including non-alcoholic fatty liver disease (NAFLD) and its
advanced form, non-alcoholic steatohepatitis (NASH), affects a significant portion of the …

Background Sarcopenia is associated with poor outcomes in patients with cirrhosis.
However, the prevalence of and associated factors for develo** sarcopenia in this …

Background & Aims Sarcopenia has significant burden in cirrhosis and has been shown to
worsen short-term post-liver transplantation (LT). This study aims to evaluate the long-term …

Liver transplant (LT) outcomes have markedly improved in the recent decades, even if long-
term morbidity and mortality are still considerable. Most of late deaths are independent from …

Introduction: Sarcopenia is increasingly recognized in patients with nonalcoholic liver
disease (NAFLD). Initially recognized as a consequence of advanced liver disease, there is …

Background: Metabolic syndrome (MS) constitutes an important source of cardiovascular-
and cancer-related morbidity and mortality in the general population. Limited information is …